12 trials newly registered in Immune System Diseases, first posted 2026-10-20, by therapeutic area, largest first. All areas.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma Lymphoma, B-Cell | Not yet recruiting | AstraZeneca | 532 | 2026-11-30 | 2026-10-20 | |
| Epcoritamab as Consolidative Therapy for Waldenstr(SqrRoot)(Delta)m Macroglobulinemia (WM) Treated With a Bruton Tyrosine Kinase Inhibitor (BTKi) epcoritamab - Waldenstrom Macroglobulinemia | Phase 2 | Not yet recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 24 | 2026-10-27 | 2026-10-22 |
| RPM Signals in Outpatient CAR T Therapy Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome | Not yet recruiting | Current Health | 125 | 2026-12-01 | 2026-10-20 | |
| Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO) Atorvastatin - Graves Disease, Graves Disease (Basedow's Disease) | Phase 2 | Not yet recruiting | Region Skane | 554 | 2026-11-01 | 2026-10-20 |
| Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program - Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent | Not applicable | Completed | Selcuk University | 70 | 2026-07-01 | 2026-10-20 |
| Bispecific Antibody-Based Holding/Bridging Therapy Before CAR-T in Aggressive B-Cell Lymphomas Glofitamab, Epcoritamab, Polatuzumab Vedotin - Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Relapsed or Refractory B-cell Lymphoma | Phase 2 | Recruiting | National Research Center for Hematology, Russia | 40 | 2026-09-01 | 2026-10-20 |
| BEX101 in B-cell Non-Hodgkin's Lymphoma BEX101 injection - Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | Recruiting | Chinese PLA General Hospital | 20 | 2026-10-15 | 2026-10-22 |
| Development of a Multidimensional Prediction Model for the Course and Outcome of Early-Onset Juvenile Idiopathic Arthritis (JIA) Juvenile Idiopathic Arthritis (JIA) | Recruiting | Istituto Giannina Gaslini | 130 | 2024-07-30 | 2026-10-20 | |
| Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI. CAR-T anti-CD19 COL01 - Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia, Lymphoid Malignancies | Phase 1 | Not yet recruiting | GUSTAVO SALGUERO | 12 | 2027-04-01 | 2026-10-20 |
| Feasibility and Acceptability of Remote Saliva Collection Salivary Cortisol Collection, Blood Biomarker Collection, Hair Cortisol Collection - Survivors of Childhood Cancer, Acute Lymphoblastic Leukemia, Childhood | Recruiting | St. Jude Children's Research Hospital | 100 | 2026-10-01 | 2026-10-20 | |
| Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating Polyneuropathy Xsens motion suit - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Not yet recruiting | Heinrich-Heine University, Duesseldorf | 50 | 2026-10-01 | 2026-10-20 | |
| Pulmonary Involvement in Children With Systemic JIA Systemic Juvenile Idiopathic Arthritis, Lung Diseases | Not yet recruiting | Assiut University | 30 | 2026-10-20 | 2026-10-20 |